Hematology

The Department of Hematology at Peking University International Hospital was established in 2014 as one of the hospital's earliest founding departments and remains a key discipline. Currently, there are over 40 chemotherapy beds and 18 transplant isolation rooms.

The team comprises more than 10 members including a chief physician, associate chief physicians, attending physicians, and technicians. The nursing staff for both chemotherapy and transplant wards totals approximately 30, with over half holding bachelor's degrees. The department maintains a well-structured talent pipeline, with all team members completing comprehensive training within the Peking University Health Science Center system. They possess solid medical theoretical knowledge and extensive clinical experience. 

The Department of Hematology specializes in hematology neoplasms, including leukemia, lymphoma, and multiple myeloma, with a focus on precise diagnosis and treatments such as chemotherapy, targeted therapy, immunotherapy, and hematopoietic stem cell transplantation. The hematology laboratory conducts a wide range of diagnostic tests and laboratory analyses. Additionally, the department possesses extensive expertise in diagnosing and treating benign hematologic disorders, including bone marrow failure syndromes, various anemias, thrombocytopenic disorders, and bleeding/clotting disorders.